ATE338558T1 - Verwendung von phosphoglyzeriden enthaltend phosphoglycero-ether zur behandlung neurodegenerativer erkrankungen in geistig schwer behinderten kindern - Google Patents
Verwendung von phosphoglyzeriden enthaltend phosphoglycero-ether zur behandlung neurodegenerativer erkrankungen in geistig schwer behinderten kindernInfo
- Publication number
- ATE338558T1 ATE338558T1 AT96924920T AT96924920T ATE338558T1 AT E338558 T1 ATE338558 T1 AT E338558T1 AT 96924920 T AT96924920 T AT 96924920T AT 96924920 T AT96924920 T AT 96924920T AT E338558 T1 ATE338558 T1 AT E338558T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- neurodegenerative diseases
- phosphoglycero
- phosphoglycerides
- ether
- Prior art date
Links
- 208000015122 neurodegenerative disease Diseases 0.000 title abstract 2
- 150000002327 glycerophospholipids Chemical class 0.000 title 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical group NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 abstract 2
- -1 phosphoglyceryl backbone Chemical group 0.000 abstract 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical group OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 abstract 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Chemical group CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 abstract 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Chemical group OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 229960001231 choline Drugs 0.000 abstract 1
- 229940031098 ethanolamine Drugs 0.000 abstract 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical group O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 abstract 1
- 229960000367 inositol Drugs 0.000 abstract 1
- 230000004770 neurodegeneration Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003248 quinolines Chemical group 0.000 abstract 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Chemical group OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 abstract 1
- 229960001153 serine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Marine Sciences & Fisheries (AREA)
- Ophthalmology & Optometry (AREA)
- Zoology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9508223A FR2736265B1 (fr) | 1995-07-07 | 1995-07-07 | Nouvelles compositions a base de phosphoglycero ethers et leur utilisation dans le traitement des maladies neuro-degeneratives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE338558T1 true ATE338558T1 (de) | 2006-09-15 |
Family
ID=9480779
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96924920T ATE338558T1 (de) | 1995-07-07 | 1996-07-02 | Verwendung von phosphoglyzeriden enthaltend phosphoglycero-ether zur behandlung neurodegenerativer erkrankungen in geistig schwer behinderten kindern |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5759585A (de) |
| EP (1) | EP0781137B1 (de) |
| JP (1) | JPH10505614A (de) |
| AT (1) | ATE338558T1 (de) |
| AU (1) | AU6521596A (de) |
| CA (1) | CA2199289C (de) |
| DE (1) | DE69636510D1 (de) |
| FR (1) | FR2736265B1 (de) |
| WO (1) | WO1997002828A1 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004026803A (ja) * | 2002-03-29 | 2004-01-29 | Nof Corp | 神経細胞死予防剤 |
| BR0316685A (pt) * | 2002-12-17 | 2005-11-01 | Nastech Pharm Co | Composições e métodos para a administração aperfeiçoada por via mucosal de peptìdeos fixadores ao receptor de y2 e métodos para tratar e prevenir a obesidade |
| EP2117527B1 (de) | 2007-02-08 | 2020-06-17 | Med-Life Discoveries LP | Verbindungen zur verwendung bei der behandlung von altersdemenz vom alzheimer-typ |
| TWI475989B (zh) | 2008-12-22 | 2015-03-11 | Phenomenome Discoveries Inc | 縮醛磷脂類化合物，含彼之醫藥組成物以及治療老化疾病的方法 |
| WO2010100060A2 (en) | 2009-03-04 | 2010-09-10 | Nestec S.A. | Method for increasing endogenous plasmalogen levels in mammals |
| KR20120114335A (ko) * | 2010-01-06 | 2012-10-16 | 마루다이 푸드 가부시키가이샤 | 뇌신경 세포 신생제 |
| KR101787618B1 (ko) * | 2010-09-24 | 2017-10-18 | 후지노 브레인 리서치 가부시키가이샤 | 항중추신경계 염증제 |
| AU2012321071B2 (en) * | 2011-11-17 | 2015-02-26 | Med-Life Discoveries Lp | Methods for the synthesis of 13C labeled plasmalogen |
| JP6603923B2 (ja) * | 2016-05-02 | 2019-11-13 | 有限会社梅田事務所 | 認知機能の改善作用を有する鶏胸肉由来プラズマローゲン組成物及びこれを含有して成る認知機能の向上及び／又は改善用食品組成物又はサプリメント |
| KR20190003570A (ko) * | 2016-05-02 | 2019-01-09 | 우메다 지무쇼 리미티드 | 안전한·안정된 플라스마로겐과 그 제제 및 인지증의 미병 상태의 판정 방법 |
| JP7309136B2 (ja) * | 2017-04-14 | 2023-07-18 | 学校法人帝京大学 | Ｈｄｌ機能改善剤及びｈｄｌ機能改善食品組成物 |
| US20230248628A1 (en) * | 2020-06-30 | 2023-08-10 | Institute Of Rheological Function Of Food Co., Ltd. | Composition for hair growth and/or hair restoration |
| US20240156845A1 (en) * | 2021-03-12 | 2024-05-16 | Institute Of Rheological Function Of Food Co., Ltd. | Composition for ameliorating inflammation of periodontal tissue |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4613621A (en) * | 1981-09-18 | 1986-09-23 | Hoerrmann Wilhelm | Fatty aldehydes and acids in the treatment of neurological and inflammatory diseases |
| DE4133080A1 (de) * | 1991-09-30 | 1993-04-01 | Schering Ag | Plasmalogenanaloga |
| IT1260149B (it) * | 1992-04-17 | 1996-03-28 | Fidia Spa | Metodo per la preparazione e purificazione di miscele di fosfolipidi prive di contaminanti da virus non convenzionali |
| FR2721516B1 (fr) * | 1994-06-27 | 1996-09-13 | Inst Rech Biolog Sa | Nouvelles utilisations d'un complexe à base de phospholipides cérébraux en thérapeutique et dans l'alimentation. |
-
1995
- 1995-07-07 FR FR9508223A patent/FR2736265B1/fr not_active Expired - Lifetime
-
1996
- 1996-07-02 US US08/809,165 patent/US5759585A/en not_active Expired - Lifetime
- 1996-07-02 AT AT96924920T patent/ATE338558T1/de not_active IP Right Cessation
- 1996-07-02 AU AU65215/96A patent/AU6521596A/en not_active Abandoned
- 1996-07-02 EP EP96924920A patent/EP0781137B1/de not_active Expired - Lifetime
- 1996-07-02 JP JP9505546A patent/JPH10505614A/ja active Pending
- 1996-07-02 DE DE69636510T patent/DE69636510D1/de not_active Expired - Lifetime
- 1996-07-02 CA CA2199289A patent/CA2199289C/fr not_active Expired - Lifetime
- 1996-07-02 WO PCT/FR1996/001028 patent/WO1997002828A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| FR2736265B1 (fr) | 1997-09-26 |
| DE69636510D1 (de) | 2006-10-19 |
| EP0781137A1 (de) | 1997-07-02 |
| AU6521596A (en) | 1997-02-10 |
| JPH10505614A (ja) | 1998-06-02 |
| WO1997002828A1 (fr) | 1997-01-30 |
| FR2736265A1 (fr) | 1997-01-10 |
| EP0781137B1 (de) | 2006-09-06 |
| CA2199289A1 (fr) | 1997-01-30 |
| US5759585A (en) | 1998-06-02 |
| CA2199289C (fr) | 2011-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE338558T1 (de) | Verwendung von phosphoglyzeriden enthaltend phosphoglycero-ether zur behandlung neurodegenerativer erkrankungen in geistig schwer behinderten kindern | |
| DE69625691D1 (de) | Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten | |
| ATE231134T1 (de) | Verwendung von dioxomorpholinen zur bekämpfung von endoparasiten, neue dioxomorpholine und verfahren zu ihrer herstellung | |
| DE59409312D1 (de) | Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten | |
| UA29505C2 (uk) | Фармацевтична композиція для лікування і/або профілактики розрідження кістки і спосіб лікування і/або профілактики розрідження кістки у ссавців | |
| DE69113848D1 (de) | Verwendung von Phosphatidylglycerol(diC 18:10) zur Behandlung obstruktiver Atemwegserkrankungen. | |
| ATE144420T1 (de) | Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen | |
| ATE411026T1 (de) | Mittel zur behandlung der alzheimer-krankheit | |
| ATE218350T1 (de) | Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen | |
| DE69427344D1 (de) | Verabreichung von riluzol zur behandlung von neuro-aids | |
| DE69535264D1 (de) | Verfahren zur behandlung von diabetes mittels kgf | |
| ATE232874T1 (de) | Prostaglandin-konjugate zur behandlung von knochenkrankheiten | |
| ATE35415T1 (de) | Pharmazeutische zusammensetzungen und verfahren fuer die herstellung von zusammensetzungen mit gehalt an phosphatidylserine zur behandlung von stoerungen des centralen nervensystems ohne wirkungen auf die blutkoagulation. | |
| ATE382061T1 (de) | Mittel zur induktion von apoptosis und zur therapieanwendung | |
| ATE157876T1 (de) | Wirkstofffreie liposomen zur behandlung von atherosklerose | |
| DE69918972D1 (de) | Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen | |
| DE69811407D1 (de) | Verwendung eines oberflächenaktiven mittels zur herstellung eines arzneimittels zur behandlung von erkrankungen des mittelohrs | |
| DE3854121D1 (de) | Arzneimittelzusammensetzungen zur behandlung von psoriasis. | |
| ATE217191T1 (de) | Verwendung von phanquinon zur behandlung von alzheimer's krankheit | |
| EE200000163A (et) | Protsess kirurgiliste instrumentide puhastamiseks | |
| DE59508366D1 (de) | Verwendung von boswelliasäure zur behandlung von hirntumoren | |
| DE59902666D1 (de) | Edelfosin zur behandlung von hirntumoren | |
| DE69829995D1 (de) | Multivalente rekombinante antikörper zur behandlung von hrv infektionen | |
| DE3865283D1 (de) | Butylhydroxyanisole zur behandlung von retrovirus-krankheiten. | |
| DE60041266D1 (de) | Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |